Childhood Cancer News

Home » Childhood Cancer News

Honoring Luke’s Legacy: Join Us This Childhood Cancer Awareness Month to Support Life-Saving Research

For most families, childhood cancer is unfathomable. But for families like Luke Getchell’s, childhood cancer is their heartbreaking, stomach-turning reality. In July of 2018, 13-year-old Luke was diagnosed with acute myeloid leukemia (AML) with a common genetic alteration, FLT3-ITD. That

Honoring Luke’s Legacy: Join Us This Childhood Cancer Awareness Month to Support Life-Saving Research Read More »

Luke - Childhood Cancer

FDA Grants Approval of New Pediatric Glioma Drug to Day One, a Biopharma Co-founded by CureSearch Board Member Dr. Samuel Blackman

Pediatric low-grade glioma (pLGG) is the most common form of pediatric brain cancer. Day One’s OJEMDA™ is the first targeted treatment for pLGG tumors with BRAF fusions and mutations. Last week, on April 23, 2024, Day One Biopharmaceuticals was granted Accelerated

FDA Grants Approval of New Pediatric Glioma Drug to Day One, a Biopharma Co-founded by CureSearch Board Member Dr. Samuel Blackman Read More »

Pin It on Pinterest

Scroll to Top